Upside case
Bull case
—
The bull case requires both strong earnings delivery and the market pricing JBS more generously than it does today.
Analysis OverviewBuyUpdated May 1, 2026
JBS N.V. (JBS) Stock Analysis
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Analyst consensus
Buy
Covering
3
analysts
3 bullish · 0 bearish · 3 covering JBS
Strong Buy
0
Buy
3
Hold
0
Sell
0
Strong Sell
0
Consensus Target
$20
+16.8% vs today
Scenario Range
— – —
Model bear to bull value window
Coverage
3
Published analyst ratings
Valuation Context
10.7x
Forward P/E · Market cap $13.6B
JBS price targets
Three scenarios for where JBS stock could go
Current
~$17
Confidence
41 / 100
Updated
May 1, 2026
Market caseClosest to today
Base case
—
The base case reflects analyst consensus expectations — steady delivery without requiring a major catalyst or re-rating.
Stress case
Bear case
—
The bear case reflects a scenario where earnings shortfalls or multiple compression combine to materially reduce the stock from its current level.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.
JBS N.V.
JBS · NYSEConsumer DefensivePackaged FoodsDecember year-end
JBS is one of the world's largest protein processors, operating as a vertically integrated meat company that slaughters, processes, and distributes beef, pork, chicken, and prepared foods globally. It generates revenue primarily from meat sales—with beef (~45%), chicken (~30%), and pork (~15%) as its main segments—alongside value-added prepared foods and byproducts like leather and biodiesel. The company's competitive advantage lies in its massive scale, vertical integration across the supply chain, and global footprint that creates cost efficiencies and market access.
Market Cap
$13.6B
Revenue TTM
$470.4B
Net Income TTM
$11.5B
Net Margin
2.4%
JBS Revenue and Earnings Performance
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
EPS Beat Rate
30%Exceptional
12 quarters tracked
Revenue Beat Rate
30%Exceptional
vs consensus estimates
Avg EPS Surprise
-34.2%
above Street consensus
Beat / Miss Record
BeatMissLeft = EPS · Right = Revenue
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Last 4 Quarters
EPS beats: 2 of 4Q2 2025
EPS
$0.23/$0.47
Revenue
$19.5B/$21.4B
Q3 2025
EPS
$0.53/$0.51
Revenue
$21.9B/$22.0B
Q4 2025
EPS
$0.52/$0.51
Revenue
$22.6B/$22.0B
Q1 2026
EPS
$0.39/$2.26
Revenue
$23.1B/$119.5B
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q2 2025 | $0.23/$0.47 | -52.4% | $19.5B/$21.4B | -8.8% |
| Q3 2025 | $0.53/$0.51 | +4.5% | $21.9B/$22.0B | -0.2% |
| Q4 2025 | $0.52/$0.51 | +2.6% | $22.6B/$22.0B | +2.9% |
| Q1 2026 | $0.39/$2.26 | -82.7% | $23.1B/$119.5B | -80.7% |
FY1–FY2 Estimates
Revenue Outlook
FY1
$439.2B
-6.6% YoY
FY2
$509.0B
+15.9% YoY
EPS Outlook
FY1
$12.29
+137.6% YoY
FY2
$13.78
+12.1% YoY
Trailing FCF (TTM)$2.0B
FCF Margin: 0.4%
Next Earnings
May 12, 2026
Expected EPS
$0.23
Expected Revenue
$21.5B
JBS beat EPS estimates in 2 of 4 tracked quarters. Mixed delivery makes the upcoming report a key data point for re-rating.
JBS Valuation Snapshot
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Relative Value Signal
Significantly Undervalued
Fair value est. $274 — implies +1601.7% from today's price.
Upside to Fair Value
1601.7%
potential upside
Deep DiscountFair ValueVery Expensive
vs S&P 500 Trailing P/E
JBS
2.7x
vs
S&P 500
25.2x
89% discount
vs Consumer Defensive Trailing P/E
JBS
2.7x
vs
Consumer Defensive
19.6x
86% discount
vs JBS 5Y Avg P/E
Today
2.7x
vs
5Y Average
—
Benchmark unavailable
Forward PE
10.7x
S&P 500
19.1x
-44%
Consumer Defensive
14.6x
-27%
5Y Avg
—
—
Trailing PE
2.7x
S&P 500
25.2x
-89%
Consumer Defensive
19.6x
-86%
5Y Avg
—
—
PEG Ratio
0.04x
S&P 500
1.75x
-98%
Consumer Defensive
1.85x
-98%
5Y Avg
—
—
EV/EBITDA
5.0x
S&P 500
15.3x
-67%
Consumer Defensive
11.4x
-56%
5Y Avg
—
—
Price/FCF
4.3x
S&P 500
21.3x
-80%
Consumer Defensive
15.7x
-72%
5Y Avg
—
—
Price/Sales
0.2x
S&P 500
3.1x
-95%
Consumer Defensive
0.8x
-81%
5Y Avg
—
—
Dividend Yield
2.43%
S&P 500
1.88%
+29%
Consumer Defensive
2.73%
-11%
5Y Avg
—
—
| Metric | JBS | S&P 500 | Consumer Defensive | 5Y Avg JBS |
|---|---|---|---|---|
| Forward PE | 10.7x | 19.1x-44% | 14.6x-27% | — |
| Trailing PE | 2.7x | 25.2x-89% | 19.6x-86% | — |
| PEG Ratio | 0.04x | 1.75x-98% | 1.85x-98% | — |
| EV/EBITDA | 5.0x | 15.3x-67% | 11.4x-56% | — |
| Price/FCF | 4.3x | 21.3x-80% | 15.7x-72% | — |
| Price/Sales | 0.2x | 3.1x-95% | 0.8x-81% | — |
| Dividend Yield | 2.43% | 1.88% | 2.73% | — |
JBS trades above S&P 500 benchmarks on 0 of 6 measured multiples — appears modestly priced relative to the S&P 500 on most measures.
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolJBS Financial Health
Verdict
Adequate
JBS 12.5% ROIC signals a durable competitive advantage — returns 2.5% of market cap to shareholders annually.
Cash Engine
Revenue, margins, and cash generation
Revenue (TTM)
Trailing-twelve-month sales base
$470.4B
Revenue Growth
TTM vs prior year
+18.6%
Gross Margin
Gross profit as a share of revenue
13.7%
Operating Margin
Operating income divided by revenue
5.0%
Net Margin
Net income divided by revenue
2.4%
EPS (TTM)
Diluted earnings per share, trailing twelve months
$5.17
Free Cash Flow (TTM)
Cash generation after capex
$2.0B
FCF Margin
FCF as share of revenue — the primary cash quality signal
0.4%
Capital Quality
ROIC, leverage, and debt serviceability
ROIC
Return on invested capital — primary competitive quality signal
12.5%
ROA
Return on assets, trailing twelve months
26.0%
Cash & Equivalents
Liquid assets on the balance sheet
$34.8B
Net Debt
Total debt minus cash
$100.2B
Debt Serviceability
Net debt as a multiple of annual free cash flow
48.9× FCF
~48.9 years to full repayment at current FCF run-rate
ROE *
Return on equity, trailing twelve months
120.6%
* Elevated by buyback-compressed equity — compare ROIC (12.5%) for an undistorted picture of capital efficiency.
Shareholder Returns
How capital is returned to owners
Total shareholder yield
2.5%
Dividend
2.4%
Buyback
0.1%
Share Repurchases
Trailing buyback outflow — dollar magnitude of capital returned
$44M
Dividend / Share
Annualized trailing dividend per share
$2.00
Payout Ratio
Share of earnings distributed as dividends
46.1%
Shares Outstanding
Declining as buybacks retire shares
814M
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt). ROE marked * where buyback-compressed equity base may inflate the figure.
Open full ratios pageJBS Stock Risk Factors
Key factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated April 29, 2026
High Risk
Debt obligations risk
JBS carries a substantial debt burden, with liabilities totaling billions of dollars. This creates a significant risk of permanent capital loss if the company fails to manage its debt obligations effectively, particularly in the event of a change of control.
High Risk
Legal and regulatory issues
The company has a history of corporate fraud and illegal activities, including bribery and financial violations, leading to significant legal exposures. Billions of dollars in proceedings are assessed as possible losses, raising concerns about compliance with U.S. anti-money laundering laws.
High Risk
Cybersecurity threats
JBS experienced a major ransomware attack in May 2021 that disrupted its global operations, highlighting the substantial cyber risks associated with its IT and operational technology systems. Such incidents can lead to significant operational and financial impacts.
Medium
Commodity price volatility
JBS's performance is susceptible to fluctuations in commodity prices and the availability of raw materials, which can impact profitability. Volatile livestock and feed costs further exacerbate this risk, affecting operational margins.
Medium
ESG compliance risks
JBS faces scrutiny regarding its environmental impact, particularly concerning deforestation compliance in Brazil and under the EU Deforestation Regulation. Past anti-corruption settlements have also raised concerns about the company's governance structure and minority shareholder rights.
Lower
Operational risks
The company is exposed to risks related to animal diseases and food safety incidents, which could affect production and sales. These operational challenges, while significant, are generally manageable within the company's existing frameworks.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Why JBS Stock Could Outperform
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated April 29, 2026
Strong Financial Performance
JBS reported record net revenue of $86.2 billion in 2025, a 12% increase from 2024, with a net profit of $2 billion, up 15%. Earnings per share (EPS) also grew by 15% to $1.89.
Global Diversification Strategy
JBS operates a global, multi-protein, and multi-platform strategy, which has proven resilient across different market conditions. Key drivers of recent performance include Pilgrim's Pride, JBS Australia, and Seara.
Impressive Brand Growth
Strong brand performance is a significant factor, with brands like Just Bare, Alamesa, Del Día, and Pilgrim's showing impressive volume growth. Just Bare is the fastest-growing brand, Alamesa has tripled its volumes, and Pilgrim's has seen an eightfold increase since 2016.
Positive Analyst Sentiment
The consensus analyst rating for JBS is 'Buy,' with a significant portion recommending 'Strong Buy'. Analysts have upgraded the stock, citing potential upside of nearly 18%.
Future Global Protein Demand
JBS expects continued strong global protein demand, driven by demographic and health trends. The company is strategically focusing on global protein diversification and value-added products to enhance margins and reduce volatility.
Potential Catalysts for Growth
A recovery in the U.S. cattle cycle could significantly benefit the North American beef segment. Additionally, the company's dual listing on the NYSE in June 2025 is expected to broaden its investor base and improve trading liquidity.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
JBS Stock Price Performance
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Current Price
$16.69
52W Range Position
69%
52-Week Range
Current price plotted between the 52-week low and high.
52-Week Low
$12.37
+34.9% from the low
52-Week High
$18.65
-10.5% from the high
1 Month
-6.66%
3 Month
+5.50%
YTD
+17.7%
1 Year
+20.3%
3Y CAGR
+6.4%
5Y CAGR
+3.8%
10Y CAGR
+1.9%
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
JBS vs Peers
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
Peer Set
Accurate peer set
Forward PE
10.7x
vs 14.1x median
-24% below peer median
Revenue Growth
-6.6%
vs +1.7% median
-495% below peer median
Net Margin
2.4%
vs 4.8% median
-49% below peer median
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
JBS JBS JBS N.V. | $13.6B | 10.7x | -6.6% | 2.4% | Buy | +16.8% |
TSN TSN Tyson Foods, Inc. | $24.2B | 17.5x | +2.2% | 0.8% | Buy | +3.2% |
HRL HRL Hormel Foods Corporation | $11.4B | 14.1x | +1.4% | 4.0% | Hold | +31.6% |
PPC PPC Pilgrim's Pride Corporation | $7.4B | 8.3x | +3.6% | 4.8% | Hold | +47.0% |
WH WH Wyndham Hotels & Resorts, Inc. | $6.3B | 17.3x | +1.7% | 13.4% | Buy | +17.8% |
SFD SFD Smithfield Foods, Inc. | $10.3B | 9.8x | -1.1% | 6.5% | Buy | +22.3% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
JBS Dividend and Capital Return
JBS returns 2.6% total yield, led by a 2.49% dividend.
Dividend SustainableFCF Stretched
Total Shareholder Yield
2.6%
Dividend + buyback return per year
Buyback Yield
0.1%
Dividend Yield
2.49%
Payout Ratio
46.1%
How JBS Splits Its Return
Div 2.49%
Dividend 2.49%Buybacks 0.1%
Dividend Profile
Yield, cadence, and growth quality
Dividend / Share
Trailing annualized cash dividend
$2.00
Growth Streak
Consecutive years of dividend increases
2Y
3Y Div CAGR
12.1%
5Y Div CAGR
45.1%
Ex-Dividend Date
—
Payment Cadence
Semi-Annual
2 payments over the last 12 months
Buyback Engine
How much per-share support comes from repurchases
Repurchases (TTM)
Cash used for buybacks in the latest trailing period
$44M
Estimated Shares Retired
3M
Approx. Share Reduction
0.3%
Shares Outstanding
Current diluted share count from the screening snapshot
814M
| Year | Div / Share | YoY Grw |
|---|---|---|
| 2026 | $1.00 | — |
| 2025 | $1.06 | +3.3% |
| 2024 | $1.02 | +162.0% |
| 2023 | $0.39 | -47.9% |
| 2022 | $0.75 | -28.3% |
FAQ
7 questionsJBS Investor Questions
Common questions answered from live analyst data and company financials.
01Is JBS N.V. (JBS) stock a buy or sell in 2026?
JBS N.V. (JBS) is rated Buy by Wall Street analysts as of 2026. Of 3 analysts covering the stock, 3 rate it Buy or Strong Buy, 0 rate it Hold, and 0 rate it Sell or Strong Sell. The consensus 12-month price target is $20, implying +16.8% from the current price of $17.
02What is the JBS stock price target for 2026?
The Wall Street consensus price target for JBS is $20 based on 3 analyst estimates. The high-end target is $23 (+37.8% from today), and the low-end target is $17 (+1.9%).
03Is JBS N.V. (JBS) stock overvalued in 2026?
JBS trades at 10.7x times forward earnings. The stock currently trades at a discount to the broader market. Based on current multiples versus the peer group, the relative model signals significantly undervalued. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
04What are the main risks for JBS N.V. (JBS) stock in 2026?
The primary risks for JBS in 2026 are: (1) Debt obligations risk — JBS carries a substantial debt burden, with liabilities totaling billions of dollars. (2) Legal and regulatory issues — The company has a history of corporate fraud and illegal activities, including bribery and financial violations, leading to significant legal exposures. (3) Cybersecurity threats — JBS experienced a major ransomware attack in May 2021 that disrupted its global operations, highlighting the substantial cyber risks associated with its IT and operational technology systems. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
05What is JBS N.V.'s revenue and earnings forecast?
Analyst consensus estimates JBS will report consensus revenue of $439.2B (-6.6% year-over-year) and EPS of $12.29 (+137.6% year-over-year) for the upcoming fiscal year. The following year, analysts project $509.0B in revenue.
06When does JBS N.V. (JBS) report its next earnings?
JBS N.V. is expected to report its next earnings on approximately 2026-05-12. Consensus expects EPS of $0.23 and revenue of $21.5B. Over recent quarters, JBS has beaten EPS estimates 30% of the time.
07How much free cash flow does JBS N.V. generate?
JBS N.V. (JBS) generated $2.0B in free cash flow over the trailing twelve months — a free cash flow margin of 0.4%. JBS returns capital to shareholders through dividends (2.5% yield) and share repurchases ($44M TTM).